SAREPTA THERAPEUTICS INC (SRPT:NASDAQ)
$15.31 0.31 (2.0667%)
Analysed SAREPTA THERAPEUTICS INC (SRPT:NASDAQ) News Sources
KROS Turns to Next Wave of TGF-Beta Muscle Therapies
22-05-2026
yahoo.com
Assessing Sarepta Therapeutics (SRPT) Valuation After Recent Share Price Weakness
26-05-2026
yahoo.com
In Solid Cash Position, Sarepta Therapeutics Inc (SRPT) Outlines 2026 Priorities
27-05-2026
yahoo.com
Sarepta Therapeutics to Participate in Upcoming Investor Conferences
01-06-2026
yahoo.com
Why Is Sarepta Therapeutics (SRPT) Down 19.9% Since Last Earnings Report?
05-06-2026
yahoo.com
Improving Profitability Supports Sarepta Therapeutics Inc. (SRPT) as One of the Most Shorted Small-Cap Stocks to Buy
06-06-2026
yahoo.com
BioGene Therapeutics Inc. Appoints Ty Howton to Board of Directors
08-06-2026
yahoo.com
SRPT vs. ARGX: Which Stock Is the Better Value Option?
08-06-2026
yahoo.com
All You Need to Know About Sarepta Therapeutics (SRPT) Rating Upgrade to Buy
08-06-2026
yahoo.com
Is Sarepta (SRPT) Using New Equity Plans To Quietly Redefine Its Post‑Profitability Playbook?
08-06-2026
yahoo.com
What is the current price of SAREPTA THERAPEUTICS INC (SRPT:NASDAQ)?
The current price of SAREPTA THERAPEUTICS INC (SRPT:NASDAQ) is $15.31.
SAREPTA THERAPEUTICS INC (SRPT:NASDAQ) absolute price change since previous trading day?
The absolute price change of SAREPTA THERAPEUTICS INC (SRPT:NASDAQ) since the previous trading day is $0.31.
SAREPTA THERAPEUTICS INC (SRPT:NASDAQ) percentage price change since previous trading day?
The percentage price change of SAREPTA THERAPEUTICS INC (SRPT:NASDAQ) since the previous trading day is 2.0667%.
What is the most recent average sentiment score for SAREPTA THERAPEUTICS INC (SRPT:NASDAQ)?
The most recent average sentiment score for SAREPTA THERAPEUTICS INC (SRPT:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for SAREPTA THERAPEUTICS INC (SRPT:NASDAQ)?
The most recent sentiment for SAREPTA THERAPEUTICS INC (SRPT:NASDAQ) is .
SEC-8K** Filing Available For SAREPTA THERAPEUTICS INC (SRPT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.